surmount-1 tirzepatide trial obesity without diabetes A 3-year study of in participants with and prediabetes showed substantial and sustained weight reduction and decreased risk of progression to with tirzepatide, as compared with placebo. Full SURMOUNT 1 // Three-Year Obesty
Description
Boswell, R
Our Tirzepatide GLP-1/GIP weight loss program starts at $75/week for a 12-week program
doi: 10.1172/JCI10842 114 da SilvaAAdo CarmoJMLiXWangZMoutonAJHallJE
These conditions make weight management more difficult and may increase the need for a medication like tirzepatide
Not finding the right medicine
We serve patients from Southampton PA, Langhorne PA, Willow Grove PA, Horsham PA, Warrington PA, Warminster PA and surrounding areas.
